Skip to content

THE effect of adding Dexmedetomidine on variation in heart rate and blood pressure after anesthesia with Thiopental sodium in electroconvulsive therapy (Ect)

A comparative study of the effect of adding Dexmedetomidin on variation in heart rate and blood pressure after the anesthesia by Thiopental sodium in children's Electroconvulsive therapy(ECT)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160307026950N13
Enrollment
60
Registered
2019-06-19
Start date
2018-03-21
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Blood pressure. Condition 2: Heart rate. Elevated blood-pressure reading, without diagnosis of hypertension Tachycardia, unspecified

Interventions

Intervention 1: Intervention group: Initially,personal consent is obtained from the parents of patients.Then the patient is placed on the operating bed and standard monitoring devices including :pulso

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 25 Years

Inclusion criteria

Inclusion criteria: Patients younger than 25 years old Patients with American society of anesthesiology physical status class 1,2 (ASA 1,ASA2) Patients candidate receiving electroconvulsive therapy Patients with satisfaction to participate in study

Exclusion criteria

Exclusion criteria: Patients with allergies to the drugs studied

Design outcomes

Primary

MeasureTime frame
Heart rate changes. Timepoint: Before the intervention,during the seizure ,1,5,10 minutes after end of seizure. Method of measurement: Heart monitoring.;Mean arterial pressure. Timepoint: Before the intervention,during seizure,1,5,10 minutes after end of seizure. Method of measurement: Non invasive blood pressure monitor.;Systolic blood pressure. Timepoint: Before the intervention , during seizure , 1,5,10 minutes after end of siezure. Method of measurement: Non invasive blood pressure monitor.;Diastolic blood pressure. Timepoint: Before the intervention , during seizure , 1,5,10 minutes after end of seizure. Method of measurement: N on invasive blood pressure monitor.;Oxygen saturation. Timepoint: Before intervention ,during seizure , 1,5,10 minutes after end of seizure. Method of measurement: Percent with pulse oximeter.;Duration of seizure. Timepoint: After intervention. Method of measurement: In second using a chornometer.;Recovery time. Timepoint: From the end of seizure to full consciousness. Method of measurement: Minute with using a chornometer.;Back up self breathing time. Timepoint: From the end of seizure until back up self breathing. Method of measurement: Seconds with using a chronometer.

Secondary

MeasureTime frame
Nausea and Vomiting. Timepoint: After end of the seizure. Method of measurement: Questionnaire.;Laryngospasm. Timepoint: After end of the seizure. Method of measurement: Evaluation of respiration and oxygen saturation.;Headache. Timepoint: After the end of seizure. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahtab Nourbakhsh

Esfahan University of Medical Sciences

mahtabnourbakhsh@yahoo.com+98 31 3662 5060

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026